Cargando…
The Role of BTK Inhibition in the Treatment of Chronic Lymphocytic Leukemia: A Clinical View
The B cell receptor (BCR) signaling pathway is functional and has critical cell survival implications in B cell malignancies, such as chronic lymphocytic leukemia (CLL). Orally administered small molecule tyrosine kinase inhibitors of members of the BCR signaling pathway have proven to be transforma...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565990/ https://www.ncbi.nlm.nih.gov/pubmed/34744463 http://dx.doi.org/10.2147/JEP.S265284 |